News Focus
News Focus
Followers 67
Posts 2909
Boards Moderated 0
Alias Born 04/22/2022

Re: HyGro post# 547020

Saturday, 12/10/2022 2:46:44 PM

Saturday, December 10, 2022 2:46:44 PM

Post# of 822802
Good point!

That’s why the pembrolizumab study is intriguing! This study uses no chemo, no radiation, and there is no mandatory crossover design. Crossover is not required because 100% of the placebo control group are receiving murcidencel.

https://clinicaltrials.gov/ct2/show/NCT04201873





Bullish
Bullish

Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News